This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Diliang Guo: Innovator in BTK Inhibitors
Introduction
Diliang Guo is a prominent inventor based in Wuhan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of BTK inhibitors. His innovative work has led to the creation of a compound that holds promise for various therapeutic applications.
Latest Patents
Diliang Guo holds 1 patent for a series of BTK inhibitors. His patent specifically discloses a compound, along with its pharmaceutically acceptable salts, tautomers, or prodrugs represented by formulas (I), (II), (III), or (IV). This invention is crucial for advancing treatment options in related medical fields.
Career Highlights
Throughout his career, Diliang Guo has worked with notable organizations, including the Hubei Bio-pharmaceutical Industrial Technological Institute and Humanwell Healthcare Co., Ltd. His experience in these institutions has allowed him to refine his expertise and contribute to groundbreaking research in pharmaceuticals.
Collaborations
Diliang Guo has collaborated with esteemed colleagues such as Xuehai Wang and Chengde Wu. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Diliang Guo's contributions to the field of BTK inhibitors exemplify his dedication to advancing pharmaceutical science. His work continues to impact the industry positively, paving the way for future innovations.